New evidence from 2022 slightly changed some perspectives for rheumatoid arthritis (RA) management. Real-world data on the efficacy and safety of disease-modifying anti-rheumatic drugs strengthened the importance of tailoring treatment decisions based on patient characteristics. Moreover, the research of response biomarkers to therapy underlined the need for precision medicine and remote care applications showed an innovative outlook that supports a patient-centred approach. New developments in vaccinations led to the release of updated guidelines and to a consistent improvement in the prevention of vaccine-preventable infections. New literature data also reconsidered drug management in RA-associated interstitial lung disease and pregnancy. In this paper, the reviewers aim to present the most relevant studies published during the last year in the field of RA management.

Garaffoni, C., Adinolfi, A., Bortoluzzi, A., Filippou, G., Giollo, A., Sakellariou, G., et al. (2023). Novel insights into the management of rheumatoid arthritis: one year in review 2023. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(11), 2129-2141 [10.55563/clinexprheumatol/nat8nl].

Novel insights into the management of rheumatoid arthritis: one year in review 2023

Scire C. A.
Ultimo
2023

Abstract

New evidence from 2022 slightly changed some perspectives for rheumatoid arthritis (RA) management. Real-world data on the efficacy and safety of disease-modifying anti-rheumatic drugs strengthened the importance of tailoring treatment decisions based on patient characteristics. Moreover, the research of response biomarkers to therapy underlined the need for precision medicine and remote care applications showed an innovative outlook that supports a patient-centred approach. New developments in vaccinations led to the release of updated guidelines and to a consistent improvement in the prevention of vaccine-preventable infections. New literature data also reconsidered drug management in RA-associated interstitial lung disease and pregnancy. In this paper, the reviewers aim to present the most relevant studies published during the last year in the field of RA management.
Articolo in rivista - Review Essay
Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Pregnancy; Vaccination
English
24-lug-2023
2023
41
11
2129
2141
reserved
Garaffoni, C., Adinolfi, A., Bortoluzzi, A., Filippou, G., Giollo, A., Sakellariou, G., et al. (2023). Novel insights into the management of rheumatoid arthritis: one year in review 2023. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(11), 2129-2141 [10.55563/clinexprheumatol/nat8nl].
File in questo prodotto:
File Dimensione Formato  
Garaffoni-2023-Clin Exp Rheumatol- VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 546.44 kB
Formato Adobe PDF
546.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/468403
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 2
Social impact